TATAA Biocenter Expands its Digital PCR offerings

19th February

TATAA Biocenter Expands its Digital PCR offerings with Stilla Technologies unique 3-color Digital PCR System Naica

Göteborg, Sweden & Stilla, France, February 20, 2018

TATAA Biocenter, Europe´s leading provider of genomic services, is expanding its digital PCR offerings with Stilla Technologies unique 3 color digital PCR system Naica. “Digital PCR is the most important complement to qPCR and NGS and can be used for standardization, copy number variation, and rare mutation analysis,” said Dr. Mikael Kubista, founder and CEO of TATAA Biocenter. “We have previously adopted the Quantstudio 12K from ThermoFisher, and the BioMark from Fluidigm, which offer simultaneous measurements of qPCR and highly specific and sensitive dPCR analysis, and QX200 from Bio-Rad and QuantStudio 3D from ThermoFisher that offer dPCR in high throughput, using a much larger number of partitions. With this addition of the Naica system we can also offer the power of 3-color digital PCR. This is major strengthening of our service and training offerings.”

Stilla Technologies is thrilled to partner with TATAA Biocenter on extending TATAA’s current offer on genomic service and hands-on digital PCR training courses. “Our system has some unique features, in particular its 3-color multiplexing capability, that provide users extended analytical power in digital PCR. We believe that these innovations, and digital PCR in general, will open new perspectives in the field of genetics,” said Magali Droniou, co-founder and Applications Director of Stilla Technologies. “This will happen only if we, as a technology provider, set education and training as one of the company’s key missions. In this effort, joining forces with TATAA Biocenter makes full sense.”

About Stilla Technologies

Stilla Technologies is a Paris-based European Biotechnology company that focuses on accelerating the development of next-generation genetic tests by providing innovative instrumentation for digital PCR (dPCR).
In 2016, Stilla Technologies launched the Naica System, the first and only digital PCR solution to offer 3-color multiplexing. By encapsulating all steps for digital PCR in a single chip, the Naica System offers a fast and user-friendly solution, rendering digital PCR accessible to all.

Stilla advises and supports its customers worldwide with a proactive and multidisciplinary R&D
team, whose expertise ranges from microfluidics and chemistry, to molecular biology and computer
science. Visit us at www.stillatechnologies.com.

About TATAA Biocenter

TATAA Biocenter is world’s largest organizer of hands-on training in molecular analyses and
Europe’s leading provider of nucleic acid analysis services in compliance with ISO17025 standard.
In 2007 TATAA Biocenter was the first company in Europe to provide digital PCR services to
researchers and published in 2008 one of the first papers featuring an application of digital PCR on
a high throughput platform (Nucleic Acids Research 36: 387, 2008). TATAA experts also coauthored
the Guidelines for Minimum Information for Publication of Quantitative Digital PCR
Experiments (Clinical Chemistry 59:6, 2013). Founded in 2001, TATAA has permanent facility in
Gothenburg, Sweden, and Prague, Czech Republic. In 2013 TATAA was presented the Frost &
Sullivan Award for Customer Value Leadership as Best-in-Class Services for Analyzing Genetic
Material. Visit us at www.tataa.com.